Market revenue in 2023 | USD 5,611.9 million |
Market revenue in 2030 | USD 7,623.2 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Fresh nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Fresh nondonor was the largest segment with a revenue share of 46.78% in 2023. Horizon Databook has segmented the North America in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
Growth of the In Vitro Fertilization (IVF) market in North America is being driven by several significant factors, including regulatory reforms, government funding for egg/sperm storage, standardization of procedures through automation, and the introduction of new IVF treatments by industry players.
These factors collectively contribute to the expansion & advancement of the IVF market in the region. Furthermore, due to the relatively higher costs of IVF and ICSI treatments in North America, the region is expected to experience steady growth during the forecast period.
For instance, according to recent data by Fertility IQ, a patient spends around USD 20,000 for a single IVF cycle in the U.S. Hence, the increasing cost of IVF treatments, combined with the growing demand in the U.S., has led to a trend where patients are traveling to other countries for treatment.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America in vitro fertilization market , including forecasts for subscribers. This continent databook contains high-level insights into North America in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account